Scarica l'app Stockscreener
20.06
2.76%
-0.57
Pre-mercato:
20.90
0.84
+4.19%
Precedente Chiudi:
$20.63
Aprire:
$20.46
Volume 24 ore:
557.60K
Relative Volume:
0.83
Capitalizzazione di mercato:
$1.03B
Reddito:
$379.81M
Utile/perdita netta:
$-21.35M
Rapporto P/E:
-50.87
EPS:
-0.3943
Flusso di cassa netto:
$35.44M
1 W Prestazione:
-10.53%
1M Prestazione:
+14.24%
6M Prestazione:
+36.46%
1 anno Prestazione:
+12.44%
Intervallo 1D:
$19.08
$20.77
Intervallo di 1 settimana:
$19.08
$23.24
Portata 52W:
$10.96
$23.24
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.06 | 1.06B | 379.81M | -21.35M | 35.44M | -0.3943 |
TMO
Thermo Fisher Scientific Inc
|
466.70 | 194.94B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
178.57 | 137.69B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.93 | 45.19B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.42 | 34.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
311.20 | 32.91B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
CareDx (NASDAQ: CDNA) boosts CFO/COO pay with new RSU and PRSU grants - Stock Titan
CDNA (CareDx Inc.) Q4 2025 EPS falls 50 percent short of estimates, sending stock down 4.46 percent today. - Xã Vĩnh Công
CDNA (CareDx Inc.) shares rise 27.6 percent despite fourth quarter 2025 earnings missing analyst projections by a wide margin.Direct Listing - Cổng thông tin điện tử tỉnh Lào Cai
CareDx (NASDAQ: CDNA) CFO & COO granted 24,134 RSUs in equity award - Stock Titan
CDNA (CareDx Inc.) posts 50.8 percent Q4 2025 EPS miss, shares dip 0.34 percent in today’s trading. - UBND thành phố Hải Phòng
CareDx sharpens focus on core testing services - MSN
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting - BioSpace
Keith Kennedy to Assume Dual Role at CareDx - Medical Product Outsourcing
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing - Yahoo Finance
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx CEO John Hanna Jr. sells $217,155 in company stock - Investing.com
CareDx (CDNA) CEO sells 10,282 shares at $21.12 under Rule 10b5-1 plan - Stock Titan
CareDx (CDNA) to Sell Lab Products Division to EuroBio Scientifi - GuruFocus
CareDx (CDNA) Launches Innovative AlloSeq Nano Genotyping Soluti - GuruFocus
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing - BioSpace
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns - Yahoo Finance
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results - Seeking Alpha
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy - Yahoo Finance
Analysts Conflicted on These Healthcare Names: CareDx (CDNA) and Pfizer (PFE) - The Globe and Mail
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo! Finance Canada
Sumitomo Mitsui Trust Group Inc. Trims Stake in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential And Analyst Consensus - DirectorsTalk Interviews
CareDx Sharpens Focus On Core Testing Services - Sahm
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments By Investing.com - Investing.com Australia
CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors - GuruFocus
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments - Investing.com
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) CEO has 62,049 shares withheld to cover RSU tax bill - Stock Titan
CareDx Up 28%, on Track for Largest Percent Increase Since May 2024 -- Data Talk - Moomoo
CareDx (NASDAQ:CDNA) Reaches New 1-Year HighHere's Why - MarketBeat
CareDx Sells Lab Products Business to EuroBio Scientific for $170 Million, Reports 48% Growth in Testing Services Revenue - Minichart
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday - Benzinga
CareDx Divests Lab Products to Refocus on Core Growth - TipRanks
CDNA Reports 17% Increase in Q1 Testing Service Volume - GuruFocus
CareDx (NASDAQ: CDNA) divests Lab Products business in $170M Eurobio deal - Stock Titan
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division - marketscreener.com
CareDx (CDNA) Soars After Divestiture Announcement and Strong Re - GuruFocus
CareDx (CDNA) Sells Lab Products Division for $170M - GuruFocus
CareDx to sell lab products unit for $170 million in cash - Investing.com India
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing - National Today
(CDNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Caredx announces agreement to divest lab products business to Eurobio Scientific for $170 million and announces first quarter preliminary financial results - marketscreener.com
CareDx (CDNA) Sees 20% Surge Following Q1 Pre-Announcement - GuruFocus
CareDx to Sell Lab Products Business for $170 Million; Shares Rise After-Hours - marketscreener.com
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results - Yahoo Finance
CareDx and Omada Health Compared: Which Medical Stock Stands Out? - National Today
CareDx (CDNA) Stock Hold Rating (Volatility Increases) 2026-04-15Sector Leader - Cổng thông tin điện tử Tỉnh Sơn La
CareDx (CDNA) Q4 Earnings Miss Estimates - Eastern Progress
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks - Yahoo Finance
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):